United States · FDA National Drug Code directory
Susvimo
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50242-078_2850382e-4e4f-4005-a047-33fc758bafef
- Product NDC
- 50242-078
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Ranibizumab
- Labeler
- Genentech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20211022
- Source listing expiry
- 20261231
Source-listed ingredients
- RANIBIZUMAB — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (50242-078-12) / 1 mL in 1 VIAL · 50242-078-12
- 1 VIAL in 1 CARTON (50242-078-55) / 1 mL in 1 VIAL · 50242-078-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →